These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring. Batool SM; Yekula A; Khanna P; Hsia T; Gamblin AS; Ekanayake E; Escobedo AK; You DG; Castro CM; Im H; Kilic T; Garlin MA; Skog J; Dinulescu DM; Dudley J; Agrawal N; Cheng J; Abtin F; Aberle DR; Chia D; Elashoff D; Grognan T; Krysan K; Oh SS; Strom C; Tu M; Wei F; Xian RR; Skates SJ; Zhang DY; Trinh T; Watson M; Aft R; Rawal S; Agarwal A; Kesmodel SB; Yang C; Shen C; Hochberg FH; Wong DTW; Patel AA; Papadopoulos N; Bettegowda C; Cote RJ; Srivastava S; Lee H; Carter BS; Balaj L Cell Rep Med; 2023 Oct; 4(10):101198. PubMed ID: 37716353 [TBL] [Abstract][Full Text] [Related]
26. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer. Takai E; Yachida S World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960 [TBL] [Abstract][Full Text] [Related]
27. Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma. Lehrich BM; Zhang J; Monga SP; Dhanasekaran R J Hepatol; 2024 Mar; 80(3):515-530. PubMed ID: 38104635 [TBL] [Abstract][Full Text] [Related]
29. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles. Li W; Wang H; Zhao Z; Gao H; Liu C; Zhu L; Wang C; Yang Y Adv Mater; 2019 Nov; 31(45):e1805344. PubMed ID: 30589111 [TBL] [Abstract][Full Text] [Related]
30. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Ye Q; Ling S; Zheng S; Xu X Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959 [TBL] [Abstract][Full Text] [Related]
31. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies. Jiang P; Chan KCA; Lo YMD J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682 [TBL] [Abstract][Full Text] [Related]
32. Liquid Biopsy: A Game Changer for Type 2 Diabetes. Gradisteanu Pircalabioru G; Musat M; Elian V; Iliescu C Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473908 [TBL] [Abstract][Full Text] [Related]
33. Liquid biopsies for hepatocellular carcinoma. Su YH; Kim AK; Jain S Transl Res; 2018 Nov; 201():84-97. PubMed ID: 30056068 [TBL] [Abstract][Full Text] [Related]
34. The Role of Liquid Biopsies in Pediatric Brain Tumors. Tang K; Gardner S; Snuderl M J Neuropathol Exp Neurol; 2020 Sep; 79(9):934-940. PubMed ID: 32766689 [TBL] [Abstract][Full Text] [Related]
35. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future. Pink RC; Beaman EM; Samuel P; Brooks SA; Carter DRF Br J Cancer; 2022 Feb; 126(3):323-330. PubMed ID: 35013578 [TBL] [Abstract][Full Text] [Related]
36. Harnessing extracellular vesicles using liquid biopsy for cancer diagnosis and monitoring: highlights from AACR Annual Meeting 2024. Su X; Shan Z; Duan S J Hematol Oncol; 2024 Jul; 17(1):55. PubMed ID: 39075488 [TBL] [Abstract][Full Text] [Related]
37. Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine. Rossi G; Ignatiadis M Cancer Res; 2019 Jun; 79(11):2798-2804. PubMed ID: 31109952 [TBL] [Abstract][Full Text] [Related]
38. The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities. Zaporozhchenko IA; Ponomaryova AA; Rykova EY; Laktionov PP Expert Rev Mol Diagn; 2018 Feb; 18(2):133-145. PubMed ID: 29307231 [TBL] [Abstract][Full Text] [Related]
39. Liquid biopsy: A new avenue in pathology. Ghosh RK; Pandey T; Dey P Cytopathology; 2019 Mar; 30(2):138-143. PubMed ID: 30485558 [TBL] [Abstract][Full Text] [Related]
40. Prostate cancer and liquid biopsies: Clinical applications and challenges. Urabe F; Sumiyoshi T; Tashiro K; Goto T; Kimura T; Kobayashi T Int J Urol; 2024 Jun; 31(6):617-626. PubMed ID: 38551314 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]